Open House Drug Discount Agreements For The Active Ingredients Adapalene And Benzoyl Peroxide Atc D10Ad23

Deadline: 01 Jan 2028

Germany

Ref. No.: 24045131

EMD:Ref Document

Bid Value: Ref Document

418 Days Left

Open House Drug Discount Agreements For The Active Ingredient Anakinra Atc L04Ac03

Deadline: 01 Jan 2028

Germany

Ref. No.: 24044858

EMD:Ref Document

Bid Value: Ref Document

418 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegfilgrastim Atc L03Aa13 For The Period March 1 2026 February 29 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jan 2029

Germany

Ref. No.: 24044312

EMD:Ref Document

Bid Value: Ref Document

788 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Potassium Iodide Atc H03Ca01 For The Period March 1 2026 February 29 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jan 2029

Germany

Ref. No.: 24044307

EMD:Ref Document

Bid Value: Ref Document

788 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Vilanterol Fluticasone Atc Code According To Who R03Ak10

Deadline: 31 Mar 2028

Germany

Ref. No.: 24044268

EMD:Ref Document

Bid Value: Ref Document

508 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Formoterol Glycopyrronium Atc Code According To Who R03Al07

Deadline: 29 Feb 2028

Germany

Ref. No.: 24044262

EMD:Ref Document

Bid Value: Ref Document

477 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Hydrocortisone Atc Code According To Who H02Ab09

Deadline: 31 Mar 2028

Germany

Ref. No.: 24044251

EMD:Ref Document

Bid Value: Ref Document

508 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Umeclidinium Atc Code According To Who R03Bb07

Deadline: 29 Feb 2028

Germany

Ref. No.: 24044247

EMD:Ref Document

Bid Value: Ref Document

477 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Metronidazole Atc D06Bx01 For The Period March 1 2026 February 29 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jan 2029

Germany

Ref. No.: 24044146

EMD:Ref Document

Bid Value: Ref Document

788 Days Left

Open House Drug Discount Agreements For The Active Ingredient Relugolix Atc L02Bx04

Deadline: 01 Jan 2028

Germany

Ref. No.: 24043811

EMD:Ref Document

Bid Value: Ref Document

418 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Isosorbide Mononitrate Atc C01Da14 For The Period March 1 2026 February 29 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jan 2029

Germany

Ref. No.: 24043415

EMD:Ref Document

Bid Value: Ref Document

788 Days Left

List Of Contracts Concluded In 2025

Deadline: 31 Dec 2026

France

Ref. No.: 24043402

EMD:Ref Document

Bid Value: Ref Document

52 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Budesonide Atc A07Ea06 For The Period March 1 2026 February 29 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jan 2029

Germany

Ref. No.: 24043397

EMD:Ref Document

Bid Value: Ref Document

788 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegfilgrastim Atc L03Aa13 For The Period March 1 2026 February 29 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jan 2029

Germany

Ref. No.: 24043249

EMD:Ref Document

Bid Value: Ref Document

788 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Potassium Iodide Atc H03Ca01 For The Period March 1 2026 February 29 2028 Plus Extension Option 1X12 Months

Deadline: 05 Jan 2029

Germany

Ref. No.: 24043027

EMD:Ref Document

Bid Value: Ref Document

788 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!